Valeant Ex-CFO Schiller Named Interim CEO With Pearson Ill

  • Ingram to become interim chairman during chief's medical leave
  • Naming single CEO said to clarify management structure

Why Schiller as Interim CEO Is Good for Valeant

Valeant Pharmaceuticals International Inc. named Howard Schiller to run the company as interim chief executive officer, tapping a board member and former top executive to help restore the company’s image while Michael Pearson remains hospitalized with severe pneumonia.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.